180 related articles for article (PubMed ID: 27519464)
1. Coumarin derivatives as potential inhibitors of acetylcholinesterase: Synthesis, molecular docking and biological studies.
Singla S; Piplani P
Bioorg Med Chem; 2016 Oct; 24(19):4587-4599. PubMed ID: 27519464
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of novel coumarin derivatives as potential acetylcholinesterase inhibitors for Alzheimer's disease.
Amin KM; Abdel Rahman DE; Abdelrasheed Allam H; El-Zoheiry HH
Bioorg Chem; 2021 May; 110():104792. PubMed ID: 33799178
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of substituted 4-methyl-2-oxo-2H-chromen-7-yl phenyl carbamates as potent acetylcholinesterase inhibitors and anti- amnestic agents.
Anand P; Singh B
Med Chem; 2013 Aug; 9(5):694-702. PubMed ID: 23072555
[TBL] [Abstract][Full Text] [Related]
4. Ameliorative effects of amide derivatives of 1,3,4-thiadiazoles on scopolamine induced cognitive dysfunction.
Kulshreshtha A; Piplani P
Eur J Med Chem; 2016 Oct; 122():557-573. PubMed ID: 27448914
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of some acridine-piperazine hybrids for the improvement of cognitive dysfunction.
Sharma A; Piplani P
Chem Biol Drug Des; 2017 Nov; 90(5):926-935. PubMed ID: 28544619
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of 4-substituted coumarins as novel acetylcholinesterase inhibitors.
Razavi SF; Khoobi M; Nadri H; Sakhteman A; Moradi A; Emami S; Foroumadi A; Shafiee A
Eur J Med Chem; 2013 Jun; 64():252-9. PubMed ID: 23644208
[TBL] [Abstract][Full Text] [Related]
7. Discovery of Potent Dual Binding Site Acetylcholinesterase Inhibitors via Homo- and Heterodimerization of Coumarin-Based Moieties.
Pisani L; Catto M; De Palma A; Farina R; Cellamare S; Altomare CD
ChemMedChem; 2017 Aug; 12(16):1349-1358. PubMed ID: 28570763
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, in vitro acetylcholinesterase inhibitory activity and molecular docking of new acridine-coumarin hybrids.
Hamulakova S; Janovec L; Soukup O; Jun D; Kuca K
Int J Biol Macromol; 2017 Nov; 104(Pt A):333-338. PubMed ID: 28601645
[TBL] [Abstract][Full Text] [Related]
9. Neurobehavioral investigation and acetylcholinesterase inhibitory activity study for some new coumarin derivatives.
Mahmoud WR; Nissan YM; Elsawah MM; Refaey RH; Ragab MF; Amin KM
Eur J Med Chem; 2019 Nov; 182():111651. PubMed ID: 31479975
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and anticholinesterase activity of coumarin-3-carboxamides bearing tryptamine moiety.
Ghanei-Nasab S; Khoobi M; Hadizadeh F; Marjani A; Moradi A; Nadri H; Emami S; Foroumadi A; Shafiee A
Eur J Med Chem; 2016 Oct; 121():40-46. PubMed ID: 27214510
[TBL] [Abstract][Full Text] [Related]
11. Novel coumarin-3-carboxamides bearing N-benzylpiperidine moiety as potent acetylcholinesterase inhibitors.
Asadipour A; Alipour M; Jafari M; Khoobi M; Emami S; Nadri H; Sakhteman A; Moradi A; Sheibani V; Homayouni Moghadam F; Shafiee A; Foroumadi A
Eur J Med Chem; 2013; 70():623-30. PubMed ID: 24211638
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel tacrine derivatives and tacrine-coumarin hybrids as cholinesterase inhibitors.
Hamulakova S; Janovec L; Hrabinova M; Spilovska K; Korabecny J; Kristian P; Kuca K; Imrich J
J Med Chem; 2014 Aug; 57(16):7073-84. PubMed ID: 25089370
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of some new 3-coumaranone and coumarin derivatives as dual inhibitors of acetyl- and butyrylcholinesterase.
Alipour M; Khoobi M; Nadri H; Sakhteman A; Moradi A; Ghandi M; Foroumadi A; Shafiee A
Arch Pharm (Weinheim); 2013 Aug; 346(8):577-87. PubMed ID: 23852709
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents.
Shaik JB; Palaka BK; Penumala M; Kotapati KV; Devineni SR; Eadlapalli S; Darla MM; Ampasala DR; Vadde R; Amooru GD
Eur J Med Chem; 2016 Jan; 107():219-32. PubMed ID: 26588065
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and evaluation of some N-methylenebenzenamine derivatives as selective acetylcholinesterase (AChE) inhibitor and antioxidant to enhance learning and memory.
Shrivastava SK; Srivastava P; Upendra TVR; Tripathi PN; Sinha SK
Bioorg Med Chem; 2017 Feb; 25(4):1471-1480. PubMed ID: 28126439
[TBL] [Abstract][Full Text] [Related]
16. Novel coumarin derivatives bearing N-benzyl pyridinium moiety: potent and dual binding site acetylcholinesterase inhibitors.
Alipour M; Khoobi M; Foroumadi A; Nadri H; Moradi A; Sakhteman A; Ghandi M; Shafiee A
Bioorg Med Chem; 2012 Dec; 20(24):7214-22. PubMed ID: 23140986
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, cholinesterase inhibition and molecular modelling studies of coumarin linked thiourea derivatives.
Saeed A; Zaib S; Ashraf S; Iftikhar J; Muddassar M; Zhang KY; Iqbal J
Bioorg Chem; 2015 Dec; 63():58-63. PubMed ID: 26440714
[TBL] [Abstract][Full Text] [Related]
18. Exploration of multi-target potential of chromen-4-one based compounds in Alzheimer's disease: Design, synthesis and biological evaluations.
Singh M; Kaur M; Singh N; Silakari O
Bioorg Med Chem; 2017 Dec; 25(24):6273-6285. PubMed ID: 29089261
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, antioxidant and anticholinesterase activities of novel coumarylthiazole derivatives.
Kurt BZ; Gazioglu I; Sonmez F; Kucukislamoglu M
Bioorg Chem; 2015 Apr; 59():80-90. PubMed ID: 25706320
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors.
Lan JS; Zhang T; Liu Y; Yang J; Xie SS; Liu J; Miao ZY; Ding Y
Eur J Med Chem; 2017 Jun; 133():184-196. PubMed ID: 28388521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]